Video

Plastic & Reconstructive Surgery Case Study | Using Soft Tissue from Twins in Breast Reconstruction

With a breast cancer patient facing limited options for reconstructive surgery after her body rejected breast implants, Wong Moon, MD, FACS, Associate Professor of Oncology at Roswell Park Comprehensive Cancer Center, found an innovative ...

Video

Why Roswell Park for your Patients Breast Cancer Treatment

Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Comprehensive Cancer Center shares the newest innovations of breast cancer treatment at Roswell Park and why to choose Roswell Park for your patient’s care.

Video

Updates in the Management of Breast Cancer

Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.

News

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center will evaluate the potential of a “molecular glue” to treat MAPK pathway-mutated advanced solid tumors in patients who have exhausted standard treatment options.

News

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...

News

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Encouraging results from a phase 1 clinical trial conducted at Roswell Park Comprehensive Cancer Center between 2019-2020 have laid the foundation for a phase 1/2a study for patients with metastatic or unresectable triple negative breast cancer (mTNBC)

News

Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024

Roswell Park Comprehensive Cancer Center made its debut on the Forbes list of America’s Best Employers for Women 2024, ranking in the top one-quarter among the 600 organizations included.

News

Can FDG-PET/CT Inform Neoadjuvant Therapy for Patients with HER2+ Breast Cancer?

Investigators hope that a phase 2 clinical trial currently underway at Roswell Park Comprehensive Cancer Center will help guide future decisions about neoadjuvant chemotherapy for patients with HER2+ breast cancer, which accounts for about ...

News

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Region’s only Comprehensive Cancer Center earns maximum rating, marking five decades of consecutive NCI support.